We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Expert Opinion / Cases · April 08, 2019

pCR After 2 Cycles of TCHP

aisha alharbi

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Elchin  Mansurov

    I’d shift her to pacli and trastuzumab. Not common to see cases on dual anti her2 complicated with wound infection. 


  • nagib khoury

    keep her on HP to compete 1 year


  • Sep 27, 2020

    Pending Moderator approval.
    Delete

Further Reading